logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
Showing 1 - 20 of 20 Items
Showing 1 - 20 of 20 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

Affordable blood culture systems from China: in vitro evaluation for use in resource-limited settings

Hardy L, Vermoesen T, Genbrugge E, Natale A, Franquesa C,  et al.
2024-03-01 • EBioMedicine
2024-03-01 • EBioMedicine
BACKGROUND
Bloodstream infections (BSI) pose a significant threat due to high mortality rates and the challenges posed by antimicrobial resistance (AMR). In 2019, an estimated 4.95 m...
Journal Article
|
Research

Predictive performance of interferon-gamma release assays and the tuberculin skin test for incident tuberculosis: an individual participant data meta-analysis

Hamada Y, Gupta RS, Quartagno M, Izzard A, Acuna-Villaorduna C,  et al.
2023-02-01 • eClinicalMedicine
2023-02-01 • eClinicalMedicine
BACKGROUND
Evidence on the comparative performance of purified protein derivative tuberculin skin tests (TST) and interferon-gamma release assays (IGRA) for predicting incident activ...
Journal Article
|
Research

Comparing Yield and Relative Costs of WHO TB Screening Algorithms in Selected Risk Groups Among People Aged 65 Years and Over in China, 2013

Zhang C, Ruan Y, Cheng J, Zhao F, Xia Y,  et al.
2017-06-08 • PLOS One
2017-06-08 • PLOS One
To calculate the yield and cost per diagnosed tuberculosis (TB) case for three World Health Organization screening algorithms and one using the Chinese National TB program (NTP) TB suspe...
Journal Article
|
Research

Screening of patients with diabetes mellitus for tuberculosis in China

Lin YD, Li L, Mi F, Du J, Dong Y,  et al.
2012-07-25 • Tropical Medicine and International Health
2012-07-25 • Tropical Medicine and International Health
OBJECTIVE
There is a high burden of both diabetes (DM) and tuberculosis (TB) in China, and as DM increases the risk of TB and adversely affects TB treatment outcomes, there is a need...
Journal Article
|
Commentary

From China: hope and lessons for COVID-19 control

Azman AS, Luquero FJ
2020-04-02 • Lancet Infectious Diseases
2020-04-02 • Lancet Infectious Diseases
Journal Article
|
Research

CMV retinitis in China and SE Asia: the way forward

Heiden D, Saranchuk P
2011-11-24 • BMC Infectious Diseases
2011-11-24 • BMC Infectious Diseases
AIDS-related CMV retinitis is a common clinical problem in patients with advanced HIV/AIDS in China and Southeast Asia. The disease is causing blindness, and current clinical management,...
Journal Article
|
Research

The looming epidemic of diabetes-associated tuberculosis: learning lessons from HIV-associated tuberculosis

Harries AD, Lin YD, Satyanarayana S, Lonnroth K, Li L,  et al.
2011-09-06 • International Journal of Tuberculosis and Lung Disease
2011-09-06 • International Journal of Tuberculosis and Lung Disease
The prevalence of diabetes mellitus is increasing at a dramatic rate, and countries in Asia, particularly India and China, will bear the brunt of this epidemic. Persons with diabetes hav...
Journal Article
|
Research

Out-of-pocket costs of AIDS care in China: are free antiretroviral drugs enough?

Moon S, Van Leemput L, Durier N, Jambert E, Dahmane A,  et al.
2008-09-01 • AIDS Care
2008-09-01 • AIDS Care
Financial access to HIV care and treatment can be difficult for many people in China, where the government provides free antiretroviral drugs but does not cover the cost of other medical...
Journal Article
|
Research

Treatment outcomes of patients on Second-line Antiretroviral Therapy in resource-limited settings: A Systematic Review and Meta-Analysis

Ajose O, Mookerjee S, Mills EJ, Boulle AM, Ford NP
2012-05-15 • AIDS
2012-05-15 • AIDS
A growing proportion of patients on antiretroviral therapy in resource-limited settings have switched to second-line regimens. We carried out a systematic review in order to summarize re...
Journal Article
|
Research

Incidence, risk factors and causes of death in an HIV care programme with a large proportion of injecting drug users

Spillane H, Nicholas S, Tang Zhirong, Szumilin E, Balkan S,  et al.
2012-08-05 • Tropical Medicine and International Health
2012-08-05 • Tropical Medicine and International Health
OBJECTIVES
To identify factors influencing mortality in an HIV programme providing care to large numbers of injecting drug users (IDUs) and patients co-infected with hepatitis C (HCV...
Journal Article
|
Research

Antibiotic prescribing for upper respiratory infections among children in rural China: a cross-sectional study of outpatient prescriptions

Zhang Z, Hu Y, Zou G, Lin MF, Zeng J,  et al.
2017-05-02 • Global Health Action
2017-05-02 • Global Health Action
BACKGROUND
Overuse of antibiotics contributes to the development of antimicrobial resistance.

OBJECTIVE
This study aims to assess the condition of antibiotic use at heal...
Journal Article
|
Commentary

Training clinicians treating HIV to diagnose cytomegalovirus retinitis

Heiden D, Tun NL, Maningding E, Heiden M, Rose-Nussbaumer J,  et al.
2014-09-22 • Bulletin of the World Health Organization
2014-09-22 • Bulletin of the World Health Organization
PROBLEM
Acquired immunodeficiency syndrome (AIDS)-related cytomegalovirus (CMV) retinitis continues to be a neglected source of blindness in resource-poor settings. The main issue is...
Journal Article
|
Research

Antiretroviral therapy outcomes in resource-limited settings for HIV-infected children <5 years of age

Sauvageot D, Schaefer MM, Olson D, Pujades-Rodriguez M, O'Brien DP
2010-05-01 • BMC Pediatrics
2010-05-01 • BMC Pediatrics
OBJECTIVE: We describe medium-term outcomes for young children receiving antiretroviral therapy (ART) in resource-limited countries. METHODS: Analyses were conducted on surveillance data...
Journal Article
|
Research

Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage

Merker M, Blin C, Mona S, Duforet-Frebourg N, Lecher S,  et al.
2015-01-19 • Nature Genetics
2015-01-19 • Nature Genetics
Mycobacterium tuberculosis strains of the Beijing lineage are globally distributed and are associated with the massive spread of multidrug-resistant (MDR) tuberculosis in Eurasia. Here w...
Journal Article
|
Research

Building leadership capacity and future leaders in operational research in low-income countries: why and how?

Zachariah R, Reid AJ, Srinath S, Chakaya JM, Legins K,  et al.
2011-11-01 • International Journal of Tuberculosis and Lung Disease
2011-11-01 • International Journal of Tuberculosis and Lung Disease
Very limited operational research (OR) emerges from programme settings in low-income countries where the greatest burden of disease lies. The price paid for this void includes a lack of ...
Journal Article
|
Research

Brief mental health interventions in conflict and emergency settings: an overview of four Medecins Sans Frontieres - France programs

Coldiron ME, Llosa AE, Roederer T, Casas G, Moro MR
2013-11-01 • Conflict and Health
2013-11-01 • Conflict and Health
INTRODUCTION
Mental health problems, particularly anxiety and mood disorders, are prevalent in the setting of humanitarian emergencies, both natural and man-made disasters. Evidence ...
Journal Article
|
Letter

Efficacy, Safety and Tolerability of Linezolid for the Treatment of XDR-TB: a Study in China

Berry C, Yates TA, Seddon JA, Phillips PPJ, du Cros PAK
2016-05-01 • European Respiratory Journal
2016-05-01 • European Respiratory Journal
Journal Article
|
Research

Screening of patients with tuberculosis for diabetes mellitus in China

Liang Li, Lin YD, Mi F, Tan S, Liang B,  et al.
2012-10-01 • Tropical Medicine and International Health
2012-10-01 • Tropical Medicine and International Health
Objective  There is a high burden of both diabetes (DM) and tuberculosis (TB) in China, and this study aimed to assess feasibility and results of screening patients with TB for DM within...
Journal Article
|
Research

Global programmatic use of bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis

Cox V, Brigden G, Crespo RH, Lessem E, Lynch S,  et al.
2018-04-01 • International Journal of Tuberculosis and Lung Disease
2018-04-01 • International Journal of Tuberculosis and Lung Disease
SETTING
The World Health Organization recommended two new drugs, bedaquiline (BDQ) and delamanid (DLM), for the treatment of multidrug-resistant tuberculosis (MDR-TB) in 2013 and 201...
Journal Article
|
Research

Chronic Hepatitis C treatment outcomes in low- and middle-income countries: a systematic review and meta-analysis

Ford NP, Kirby C, Singh KR, Mills EJ, Cooke GS,  et al.
2012-02-03 • Bulletin of the World Health Organization
2012-02-03 • Bulletin of the World Health Organization
To assess the effectiveness of treatment for hepatitis C virus (HCV) infection in low- and middle-income countries and identify factors associated with successful outcomes.